H Löffler Selected Research

BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)

9/2003	Chronic myeloid leukemia in the elderly: long-term results from randomized trials with interferon alpha.
8/2003	Randomized comparison of interferon alpha and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon alpha and hydroxyurea.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

H Löffler Research Topics

Disease

5	Contact Dermatitis (Eczema, Contact) 02/2015 - 03/2000
4	Hypersensitivity (Allergy) 02/2015 - 07/2000
2	Erythema 07/2007 - 06/2002
2	Chromosome Aberrations (Chromosome Abnormalities) 06/2005 - 01/2001
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2003 - 08/2003
2	Residual Neoplasm 08/2001 - 08/2000
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2001 - 10/2000
1	Epilepsy (Aura) 02/2016
1	Episodic Ataxia 02/2016
1	Inflammation (Inflammations) 09/2010
1	Wounds and Injuries (Trauma) 09/2010
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 09/2010
1	Type 2 Diabetes Mellitus (MODY) 09/2010
1	Hemangioma (Angioma) 12/2009
1	Exanthema (Rash) 09/2009
1	Eczema 03/2009
1	Dermatitis 03/2009
1	Urticaria (Hives) 05/2008
1	Anaphylaxis (Anaphylactic Shock) 05/2008
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 01/2005
1	Constipation 01/2005
1	Skin Diseases (Skin Disease) 07/2002
1	Body Weight (Weight, Body) 02/2002
1	Neoplasms (Cancer) 08/2001
1	Blast Crisis (Blast Phase) 01/2001
1	Acute Promyelocytic Leukemia 08/2000
1	Allergic Contact Dermatitis 07/2000

Drug/Important Bio-Agent (IBA)

5	Irritants (Vesicants)IBA 04/2005 - 03/2000
2	AlcoholsIBA 03/2009 - 07/2007
2	Detergents (Detergent)IBA 07/2007 - 09/2003
2	Interferon-alpha (Interferon Alfa)IBA 09/2003 - 08/2003
1	Sodium Channels (Sodium Channel)IBA 02/2016
1	2,2-bis(4-glycidyloxyphenyl)propaneIBA 02/2015
1	AluminumIBA 02/2015
1	Pharmaceutical PreparationsIBA 02/2015
1	Biomarkers (Surrogate Marker)IBA 09/2010
1	Blood Glucose (Blood Sugar)IBA 09/2010
1	NF-kappa B (NF-kB)IBA 09/2010
1	Glucose (Dextrose)FDA LinkGeneric 09/2010
1	Hormones (Hormone)IBA 09/2010
1	Insulin (Novolin)FDA Link 09/2010
1	Propranolol (Inderal)FDA LinkGeneric 12/2009
1	Daunorubicin (Cerubidine)FDA LinkGeneric 09/2009
1	Epoxy Resins FDA Link 05/2008
1	Ethanol (Ethyl Alcohol)IBA 07/2007
1	Hemoglobins (Hemoglobin)IBA 06/2005
1	octyl gallateIBA 04/2005
1	phenoxyethanol (2-phenoxyethanol)IBA 04/2005
1	AllergensIBA 04/2005
1	1,2-dibromo-2,4-dicyanobutaneIBA 04/2005
1	tegaserod (Zelnorm)FDA Link 01/2005
1	EmollientsIBA 09/2003
1	Hydroxyurea (Hydrea)FDA LinkGeneric 08/2003
1	InterferonsIBA 08/2003
1	Methoxsalen (Oxsoralen)FDA Link 07/2002
1	SolutionsIBA 07/2002
1	Melanins (Melanin)IBA 06/2002
1	Indicators and Reagents (Reagents)IBA 02/2002
1	Tyrosine Kinase InhibitorsIBA 01/2001
1	Imatinib Mesylate (Gleevec)FDA Link 01/2001
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 08/2000
1	Cytarabine (Cytosar-U)FDA LinkGeneric 08/2000
1	promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA 08/2000
1	CytokinesIBA 07/2000

Therapy/Procedure

6	Therapeutics 12/2009 - 08/2000
1	Induction Chemotherapy 09/2009
1	Hand Hygiene 03/2009
1	Retreatment 01/2005
1	Lasers (Laser) 06/2002
1	Homologous Transplantation 08/2001
1	Drug Therapy (Chemotherapy) 01/2001